SCHEMBL19396646

SCHEMBL19396646

c1ccc(-c2ccc(N(c3ccc4c(c3)oc3ccccc34)c3ccc4c5ccccc5c5ccccc5c5ccccc5c5c(ccc6c7ccccc7oc65)c4c3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.37
MEN1 O00255 4/20 0.36
MAPT P10636 4/20 0.36
KMT2A Q03164 4/20 0.36
HPGD P15428 3/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 2/20 0.36
ALOX5 P09917 2/20 0.36
ALPI P09923 1/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
CASP3 P42574 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36
CASP7 P55210 1/20 0.36
CASP6 P55212 1/20 0.36
MCL1 Q07820 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19397007 1.00 AHR (0.37) AHRMEN1MAPTKMT2AHPGD
SCHEMBL17658536 0.96 MAPT (0.35) AHRMEN1MAPTKMT2AHPGD
SCHEMBL19396909 0.96 ALOX5 (0.38) AHRMEN1MAPTKMT2AHPGD
SCHEMBL19396910 0.96 ALOX5 (0.38) AHRMEN1MAPTKMT2AHPGD
SCHEMBL19396380 0.95 MAPT (0.37) AHRMEN1MAPTKMT2AHPGD
SCHEMBL19396839 0.95 MAPT (0.37) AHRMEN1MAPTKMT2AHPGD
SCHEMBL19396809 0.95 ALOX5 (0.37) AHRMEN1MAPTKMT2AHPGD
SCHEMBL19396365 0.95 ALOX5 (0.37) AHRMEN1MAPTKMT2AHPGD
SCHEMBL17658484 0.94 MEN1 (0.33) MEN1MAPTKMT2AHPGDKDM4E
SCHEMBL17658483 0.92 MEN1 (0.32) MEN1MAPTKMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170279050-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170279050-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME ESRRA, ESRRB, RCOR3 AHR 231/4885MEN1 3217/4885MAPT 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.